Form D · Biotechnology

CELSENSE INC

Pittsburgh, PA · CIK 0001372965

Offering snapshot reported Feb 11, 2020 · SEC filing

Reported sold
Yet to sell
Offering amount: $500K
Investors reported
0
Form D · investor count
Minimum accepted
$5K
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 11, 2020InitialYet to sellNo comparison0SEC filing
May 21, 2018Initial$125,000No comparison2SEC filing
Apr 20, 2017Amendment$710,000$610,000vs Aug 17, 20165SEC filing
Aug 17, 2016Initial$100,000No comparison1SEC filing
Jul 6, 2016Amendment$353,000$105,000vs Dec 31, 201518SEC filing
Dec 31, 2015Initial$248,000No comparison16SEC filing
Sep 9, 2014Initial$267,500No comparison16SEC filing
Sep 9, 2014AmendmentYet to sellNo comparison0SEC filing
Oct 25, 2013InitialYet to sellNo comparison0SEC filing
Feb 28, 2012Initial$125,000No comparison9SEC filing
May 5, 2010Amendment$684,000No comparison14SEC filing
May 5, 2010InitialYet to sellNo comparison14SEC filing
Apr 7, 2010Initial$150,000No comparison1SEC filing
Jun 4, 2009Initial$761,300No comparisonNot reportedSEC filing
Apr 16, 2008PaperNot reportedNo comparisonNot reportedSEC filing
May 3, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Sep 20, 2006PaperNot reportedNo comparisonNot reportedSEC filing
Aug 14, 2006PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Debt, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-360286

Source: Form D, filed Feb 11, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

M7 FRENCH ACTIVE FUND LP

Investment adviser: M7 REAL ESTATE LTD

Gross asset value
$0
Beneficial owners
42
ADV minimum commitment
$284K

Reported in Form ADV on Apr 5, 2022. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator ALTER DOMUS (JERSEY) LIMITED ST. HELIER, Jersey Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor KPMG LLP LONDON, United Kingdom
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
No
Administrator other than the adviser
Yes
External marketing
No

KPMG LLP
PCAOB 1118

Filing source

Form ADV 1633698 · Apr 5, 2022 · Schedule D 7.B.(1), fund 805-1752042170

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Eric T. Aherns Director
Eric T. Ahrens Director
T. Ronald Casper Executive
Lourdes M. Castellanos Executive
Jeffrey S. Friedman Director
Daniel P Gallagher Director
Daniel P. Gallagher, Jr. Director
Gregory T. Hebrank Director
Ronald B. Herberman Director
Paul L. Kornblith Director
Kevin S. Mc Clatchy Director
Charles F O'hanlon Director, Executive
Charles F. O'hanlon, Iii Director, Executive
Thomas Petzinger Director
Thomas Petzinger, Jr. Director
Gerald L. Tarantino Director
L Gerald Tarantino Director
L. Gerald Tarantino Director
D. Lansing Taylor Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
603 Stanwix Street Suite 390
Pittsburgh, PA, 15222